# Azenta Inc. (AZTA) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Health Care Technology. Price $31.33, market value $1.4 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Azenta Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **PEG: 0.88**. A PEG of 0.88 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 2.2×**. Each dollar of revenue is priced at 2.2×.
- **Price / book: 0.9×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **Free-cash-flow yield: 0.7%** (5-yr avg -2.6%). Free cash flow equals 0.7% of the market value, above its five-year average of -2.6%, so the shares are cheaper on cash than they have usually been.

## Profitability
- **Gross margin: 43.8%**. Azenta Inc. keeps 43.8% of revenue after the direct cost of what it sells.
- **Operating margin: -28.7%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -9.4%**. The company reported a net loss over the last twelve months.
- **Return on equity: -3.2%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -9.3%**. Return on all capital, debt included, is -9.3%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -5.7%**. Each dollar of assets produces -5.7% of profit.

## Growth
- **Revenue growth (1 yr): 3.6%** (3-yr 2.2%/yr, 5-yr 8.9%/yr). Revenue grew 3.6% over the last year, against 8.9% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 60.6%**. Earnings per share rose 60.6%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.03**. Debt is 0.03 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 1.9×**. It would take 1.9 years of operating earnings to repay net borrowings, within the comfortable range.
- **Current ratio: 2.98** (quick 2.98). Current assets cover the next year's liabilities 2.98 times.
- **Altman Z-score: 4.17**. A Z-score of 4.17 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Azenta Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (4 analysts). 4 analysts cover Azenta Inc.; the consensus is buy, with an average price target of $35.25 (+13% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 6.1%** (YTD -5.8%, 3-mo 38.1%). The shares are up 6.1% over twelve months including dividends.
- **From 52-week high: -24.9%** (96.7% above the low). Trading 25% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 47**. An RSI of 47 is neutral.
- **Beta (1 yr): 1.60** (volatility 62%). Beta of 1.60 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=AZTA · Page: https://foliofundamentals.com/stocks/azta

Not investment advice.